Biomarkers Sector Slated for Rapid Growth

The market for biomarkers, a sector with applications in drug discovery, clinical trials, and molecular diagnostics, is growing at a CAGR of 18% and will be worth $5.6 billion in full-year 2007, according to a recent study by market research group BCC Research (Wellesley, MA). Biomarker technologies tailored to drug discovery, preclinical studies of drug development, and diagnostics research will together account for 47.9% of the biomarker market in 2007. The value of the biomarker discovery technologies market is projected to grow at a CAGR of 16.9% and is...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers